MMM vs. BMY
MMM (3M Company) and BMY (Bristol-Myers Squibb Company) are both stocks. MMM operates in Conglomerates (Industrials), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, MMM returned 4.58%/yr vs 1.00%/yr for BMY. At a 0.36 correlation, their price movements are largely independent.
Performance
MMM vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MMM achieves a -0.15% return, which is significantly lower than BMY's 8.27% return. Over the past 10 years, MMM has outperformed BMY with an annualized return of 4.58%, while BMY has yielded a comparatively lower 1.00% annualized return.
MMM
- 1D
- 0.26%
- 1M
- 8.18%
- YTD
- -0.15%
- 6M
- -5.36%
- 1Y
- 11.41%
- 3Y*
- 26.46%
- 5Y*
- 2.22%
- 10Y*
- 4.58%
BMY
- 1D
- 0.40%
- 1M
- 1.31%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 18.34%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
MMM vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MMM 3M Company | -0.15% | 26.36% | 46.13% | -3.33% | -29.63% | 4.85% | 2.77% | -4.29% | -16.90% | 34.90% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between MMM and BMY is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 1972 | 0.36 |
Fundamentals
MMM:
$84.35B
BMY:
$116.75B
MMM:
$5.17
BMY:
$3.57
MMM:
30.65
BMY:
16.02
MMM:
3.41
BMY:
2.40
MMM:
25.85
BMY:
5.82
MMM:
$25.02B
BMY:
$48.48B
MMM:
$9.89B
BMY:
$33.33B
MMM:
$5.28B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MMM vs. BMY — Risk / Return Rank
MMM
BMY
MMM vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for 3M Company (MMM) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MMM | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.24 | ||
| Sortino ratioReturn per unit of downside risk | -0.37 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.14 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.61 | 1.53 | -0.92 |
| Martin ratioReturn relative to average drawdown | 1.35 | 3.32 | -1.97 |
Loading charts...
Drawdowns
MMM vs. BMY - Drawdown Comparison
The maximum MMM drawdown since its inception was -59.10%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for MMM and BMY.
Loading charts...
Drawdown Indicators
| MMM | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.10% | -72.03% | +12.93% |
Max Drawdown (1Y)Largest decline over 1 year | -18.77% | -12.05% | -6.72% |
Max Drawdown (3Y)Largest decline over 3 years | -22.87% | -36.85% | +13.98% |
Max Drawdown (5Y)Largest decline over 5 years | -53.34% | -47.67% | -5.67% |
Max Drawdown (10Y)Largest decline over 10 years | -59.10% | -47.67% | -11.43% |
Current DrawdownCurrent decline from peak | -8.45% | -17.79% | +9.34% |
Average DrawdownAverage peak-to-trough decline | -16.10% | -22.38% | +6.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.48% | 6.34% | +2.14% |
Volatility
MMM vs. BMY - Volatility Comparison
The current volatility for 3M Company (MMM) is 6.23%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.22%. This indicates that MMM experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MMM | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.23% | 8.22% | -1.99% |
Volatility (6M)Calculated over the trailing 6-month period | 19.26% | 18.18% | +1.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.96% | 27.08% | -1.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.30% | 24.02% | +4.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.53% | 25.29% | +1.24% |
Dividends
MMM vs. BMY - Dividend Comparison
MMM's dividend yield for the trailing twelve months is around 1.91%, less than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
MMM 3M Company | 1.91% | 1.82% | 16.27% | 5.49% | 4.97% | 3.33% | 3.36% | 3.26% | 2.86% | 2.00% | 2.49% | 2.72% |
Financials
MMM vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between 3M Company and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MMM vs. BMY - Profitability Comparison
MMM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, 3M Company reported a gross profit of 2.46B and revenue of 6.03B. Therefore, the gross margin over that period was 40.7%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
MMM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, 3M Company reported an operating income of 1.40B and revenue of 6.03B, resulting in an operating margin of 23.2%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
MMM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, 3M Company reported a net income of 653.00M and revenue of 6.03B, resulting in a net margin of 10.8%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
MMM and BMY have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (8.22%) compared to MMM (6.23%). In terms of maximum drawdown, MMM dropped -59.10% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.68 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MMM and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer